Equity Capital Markets
Compass Therapeutics
08/25
|
$120.0 Million
Âé¶¹´«Ã½ served as active bookrunner for Compass Therapeutics on its CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma